AIE-Active Photosensitizer APT NPs with Type I/II ROS Generating Orchestrate the DDIT4-Centric Gene-Metabolite Axis in Photodynamic Therapy
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c19205 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2025. Written by Zhen Fang and 8 co-authors. Institution: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-M…. Major MEDLINE topics: Photosensitizing Agents, Photochemotherapy, Nanoparticles, Reactive Oxygen Species. Cited 3 times so far (Crossref); 49 references. Funded by: Department of Education of Guangdong Province, State Key Laboratory of Luminescent Materials and Devices, Quality Engineering Program of University of Electronic Science and Technology Zhongshan Institute.
Abstract (original language)
Photodynamic therapy (PDT) is a promising strategy for tumor treatment; however, the oxygen adaptation of conventional photosensitizers, coupled with the elusive mechanism, has greatly hindered their further development. Here, a novel organic aggregation-induced emission (AIE) active Schiff base photosensitizer, namely, 2-(((5-(7-(4-(diphenylamino)phenyl)benzo[c][1,2,5]thiadiazol-4-yl)thiophen-2-yl)methylene)amino)-4-phenylthiophene-3-carbonitrile (APT), is designed and synthesized. APT nanoparticles (NPs) efficiently generate both type I (hydroxyl radicals and superoxide anions) and type II (singlet oxygen) reactive oxygen species (ROS), enabling strong phototoxicity even under hypoxic conditions. In vitro, the APT NPs have minimal dark cytotoxicity and significant light-induced cytotoxicity in MCF-7 cells, with an IC50 of 4.61 μM. Importantly, multiomics analyses reveal a unique mechanism of action: APT NPs induce the upregulation of the stress-responsive gene DNA damage-inducible transcript 4 (DDIT4), which inhibits the mammalian target of the rapamycin complex 1 (mTORC1) signaling pathway. This inhibition establishes a cohesive gene-metabolite regulatory axis, triggers the downregulation of key oncogenic drivers (FBJ osteosarcoma sarcoma viral oncogene homologue (FOS) family and B-cell cell lymphoma-2 (Bcl-2)) and the disruption of valine/leucine/isoleucine biosynthesis, leading to cell cycle arrest and apoptosis. In vivo, the MCF-7 tumor-bearing mouse model confirms potent antitumor efficacy without significant side effects. This work not only introduces a hypoxia-insensitive PDT agent but also provides novel insights into the mechanistic interaction between transcriptional and metabolic regulation in PDT, highlighting the potential of AIE-active materials for cancer therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
- College of Materials and Food, University of Electronic Science and Technology Zhongshan Institute, Zhongshan 528402, Guangdong, China.
- Guangdong Ascendas Genomics Technology Co., Ltd., Zhongshan 528437, Guangdong, China.
- Department of Chemistry and Chemical Engineering, Chalmers University of Technology, SE-412 96 Göteborg, Sweden.
ORCID profiles: Ergang Wang, Yanshan Liu
Funding
- Department of Education of Guangdong Province
- State Key Laboratory of Luminescent Materials and Devices
- Quality Engineering Program of University of Electronic Science and Technology Zhongshan Institute
Cite
APA
Fang, Z., Li, M., Mai, Y., Luo, W., Wang, E., Liu, X., Yang, C., Shen, Z., & Liu, Y. (2025). AIE-Active Photosensitizer APT NPs with Type I/II ROS Generating Orchestrate the DDIT4-Centric Gene-Metabolite Axis in Photodynamic Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c19205
Vancouver
Fang Z, Li M, Mai Y, Luo W, Wang E, Liu X, et al. AIE-Active Photosensitizer APT NPs with Type I/II ROS Generating Orchestrate the DDIT4-Centric Gene-Metabolite Axis in Photodynamic Therapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c19205
BibTeX
@article{Fang2025,
author = {Fang, Zhen and Li, Mei and Mai, Yali and Luo, Wenlong and Wang, Ergang and Liu, Xinchun and Yang, Chengyong and Shen, Zhongqing and Liu, Yanshan},
title = {AIE-Active Photosensitizer APT NPs with Type I/II ROS Generating Orchestrate the DDIT4-Centric Gene-Metabolite Axis in Photodynamic Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c19205}
}
EUVIMED